Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis
Suvojit Hazra, Alok Ghosh Chaudhuri, Basant K. Tiwary, et al.
Life Sciences (2020) Vol. 257, pp. 118096-118096
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

A critical overview of computational approaches employed for COVID-19 drug discovery
Eugene Muratov, Rommie E. Amaro, Carolina Horta Andrade, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 16, pp. 9121-9151
Open Access | Times Cited: 174
Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients
Monica Gelzo, Sara Cacciapuoti, Biagio Pinchera, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 81
MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients
Carolina D`Avila-Mesquita, Ariel E.S. Couto, Ligia C.B. Campos, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 112067-112067
Open Access | Times Cited: 83
Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets
Jon Hazeldine, Janet M. Lord
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 73
Food policy, nutrition and nutraceuticals in the prevention and management of COVID-19: Advice for healthcare professionals
Yasemin Ipek Ayseli, Nazli Aytekin, Derya Büyükkayhan, et al.
Trends in Food Science & Technology (2020) Vol. 105, pp. 186-199
Open Access | Times Cited: 55
Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19
Dun‐Xian Tan, Rüdiger Hardeland
Molecules (2020) Vol. 25, Iss. 19, pp. 4410-4410
Open Access | Times Cited: 55
Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality
Dun‐Xian Tan, Rüssel J. Reiter
Life Sciences (2022) Vol. 294, pp. 120368-120368
Open Access | Times Cited: 29
Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches
Fee Faysal Ahmed, Md. Selim Reza, Md. Shahin Sarker, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266124-e0266124
Open Access | Times Cited: 29
Роль циркулирующих биомаркеров у пациентов, перенесших COVID-19
О. А. Осипова, R. N. Shepel, Ольга Анатольевна Каруцкая, et al.
Актуальные проблемы медицины (2023) Vol. 46, Iss. 3, pp. 231-244
Open Access | Times Cited: 20
COVID-19 Affects Serum Brain-Derived Neurotrophic Factor and Neurofilament Light Chain in Aged Men: Implications for Morbidity and Mortality
Carla Petrella, Maria Antonella Zingaropoli, Flavio Maria Ceci, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 655-655
Open Access | Times Cited: 19
Sex-specific differences in systemic immune responses in MIS-C children
Anuradha Rajamanickam, Nathella Pavan Kumar, Aishwarya Venkataraman, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review)
Ioannis Lempesis, Vasiliki Georgakopoulou, Rüssel J. Reiter, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 3
Open Access | Times Cited: 5
Analysis of differential expression of matrix metalloproteinases and defensins in the nasopharyngeal milieu of mild and severe COVID-19 cases
Khekashan Imtiaz, Nida Farooqui, Khalid Ahmed, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0304311-e0304311
Open Access
Pineal hormone melatonin as an adjuvant treatment for COVID‑19 (Review)
Marilena Vlachou, Angeliki Siamidi, Aikaterini Dedeloudi, et al.
International Journal of Molecular Medicine (2021) Vol. 47, Iss. 4
Open Access | Times Cited: 34
Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The Role of Bioactive Compounds and Natural Antioxidants
Kyonghwan Choe, Hyun‐Young Park, Muhammad Ikram, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1298-1298
Open Access | Times Cited: 22
New Proposal Involving Nanoformulated Melatonin Targeted to The Mitochondria as A Potential COVID-19 Treatment
Virna Margarita Martín Giménez, Natalia Jorgelina Prado, Emiliano Diez, et al.
Nanomedicine (2020) Vol. 15, Iss. 29, pp. 2819-2821
Open Access | Times Cited: 27
Oral Hsp90 inhibitor SNX-5422 attenuates SARS-CoV-2 replication and dampens inflammation in airway cells
Ria Goswami, Veronica Russell, Joshua J. Tu, et al.
iScience (2021) Vol. 24, Iss. 12, pp. 103412-103412
Open Access | Times Cited: 26
Transcriptomic studies revealed pathophysiological impact of COVID-19 to predominant health conditions
Zulkar Nain, Shital K. Barman, Md. Moinuddin Sheam, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 24
Structural characterisation of inhibitory and non-inhibitory MMP-9–TIMP-1 complexes and implications for regulatory mechanisms of MMP-9
Łukasz Charzewski, Krystiana A. Krzyśko, Bogdan Lesyng
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 23
Intricate relationship between SARS-CoV-2–induced shedding and cytokine storm generation: A signaling inflammatory pathway augmenting COVID-19
Moayed Ben Moftah, Asma Eswayah
Health Sciences Review (2022) Vol. 2, pp. 100011-100011
Open Access | Times Cited: 16
MMP-9/BDNF ratio predicts more severe COVID-19 outcomes
Goran Savić, Ivana Stevanović, Dušan Mihajlović, et al.
International Journal of Medical Sciences (2022) Vol. 19, Iss. 13, pp. 1903-1911
Open Access | Times Cited: 16
Drug repurposing against coronavirus disease 2019 (COVID-19): A review
Lianxiang Luo, Qin Qiu, Fangfang Huang, et al.
Journal of Pharmaceutical Analysis (2021) Vol. 11, Iss. 6, pp. 683-690
Open Access | Times Cited: 21
Circulating tissue inhibitor of metalloproteinases 1 (TIMP-1) at COVID-19 onset predicts severity status
Stefano Brusa, Daniela Terracciano, Dario Bruzzese, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 15
Potential usefulness of Mediterranean diet polyphenols against COVID-19-induced inflammation: a review of the current knowledge
Iñaki Milton‐Laskibar, Jenifer Trepiana, M. T. Macarulla, et al.
Journal of Physiology and Biochemistry (2022) Vol. 79, Iss. 2, pp. 371-382
Open Access | Times Cited: 14
Tissue Inhibitor of Matrix Metalloproteinases-1 (TIMP-1) and Pulmonary Involvement in COVID-19 Pneumonia
Maria Antonella Zingaropoli, Tiziana Latronico, Patrizia Pasculli, et al.
Biomolecules (2023) Vol. 13, Iss. 7, pp. 1040-1040
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top